Medical Services & Devices
Johnson & Johnson’s 2026 Q2 earnings report demonstrates strong sales growth, with the company now on track for record-breaking annual revenue performance
Johnson & Johnson’s 2026 Q2 earnings report demonstrates strong sales growth, with the company now on track for record-breaking annual revenue performance
Articles
Pharmaceutical firm Perrigo replaces CEO Patrick Lockwood-Taylor after conduct concerns, appointing an interim Chief amid strategy and nutrition review
Johnson & Johnson is acquiring Firefly Bio for US$1bn, adding its degrader antibody conjugate platform to target KRAS-driven cancers & expand oncology
As climate change drives more frequent heatwaves, health experts warn high temperatures can affect medicines, dehydration risk and treatment safety
Johnson & Johnson is acquiring Firefly Bio for US$1bn, adding its degrader antibody conjugate platform to target KRAS-driven cancers & expand oncology
Pharmaceutical firm Perrigo replaces CEO Patrick Lockwood-Taylor after conduct concerns, appointing an interim Chief amid strategy and nutrition review
The top healthcare stories this week include the impact of menopause on the workforce, the impact of precision medicine and women's health in UK strategy
Encouraging Phase 2 results show a robust immune response against serotype 3, prompting pivotal Phase 3 trials to protect up to 90% of paediatric patients
Lists
From UnitedHealthcare's Stephanie Fehr and J&J's Kristen Mulholland to McKesson's LeAnn Smith & CVS Health's Heidi Capozzi, meet the top Chief HR Officers
From Johnson & Johnson and Roche to Eli Lilly, Pfizer, Novartis, Merck & Co and AstraZeneca, these life sciences leaders are advancing healthcare systems
Videos
Early in the COVID-19 pandemic Moderna teamed up with Apply Digital to lead its digital transformation and educate the world about Moderna’s mRNA platform